SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A CANDIDATE VACCINE IN HEALTHY ADULT VOLUNTEERS

被引:78
|
作者
WIEDERMANN, G
AMBROSCH, F
KOLLARITSCH, H
HOFMANN, H
KUNZ, C
DHONDT, E
DELEM, A
ANDRE, FE
SAFARY, A
STEPHENNE, J
机构
[1] UNIV VIENNA,INST VIROL,A-1010 VIENNA,AUSTRIA
[2] SMITH KLINE BIOL,RIXENSART,BELGIUM
关键词
Candidate vaccine; ELISA; hepatitis A; inactivated;
D O I
10.1016/0264-410X(90)90013-C
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The reactogenicity and immunogenicity of a formaldehyde-inactivated hepatitis A vaccine have been investigated. Three different dose levels of vaccine (180, 360 and 720 ELISA units) were administered to healthy volunteers according to a 0, 1, 2 and 12 month schedule. The vaccine was safe and well tolerated. Reactions observed following vaccination were essentially mild and were not dependent upon the quantity of antigen administered. All subjects had measurable titres of anti-HAV antibodies after the full vaccination course; the immune response to the vaccine was dose-related. Antibody titres in vaccinees at month 13 were between 60- and 190-fold higher than those observed in a group of subjects given anti-HAV immunoglobulin. © 1990.
引用
收藏
页码:581 / 584
页数:4
相关论文
共 50 条
  • [21] SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VIRUS-VACCINE IN PRESCHOOL-CHILDREN
    BALCAREK, KB
    BAGLEY, MR
    PASS, RF
    KRAUSE, D
    CLINICAL RESEARCH, 1993, 41 (04): : A766 - A766
  • [22] SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS A VACCINE
    WESTBLOM, TU
    GUDIPATI, S
    DEROUSSE, C
    MIDKIFF, BR
    BELSHE, RB
    CLINICAL RESEARCH, 1991, 39 (03): : A727 - A727
  • [23] SAFETY AND IMMUNOGENICITY OF A LIVE ATTENUATED HEPATITIS-A VIRUS-VACCINE IN SERONEGATIVE VOLUNTEERS
    MIDTHUN, K
    ELLERBECK, E
    GERSHMAN, K
    CALANDRA, G
    KRAH, D
    MCCAUGHTRY, M
    NALIN, D
    PROVOST, P
    JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04): : 735 - 739
  • [24] GOOD IMMUNOGENICITY OF GBM STRAIN INACTIVATED HEPATITIS-A VACCINE IN HEALTHY MALE-ADULTS
    GARIN, D
    VIDOR, E
    WALLON, M
    FANGET, B
    BRASSEUR, P
    DELOLME, H
    CARON, F
    MOJON, M
    GRAVEY, A
    HUMBERT, G
    FLEHMIG, B
    PEYRON, F
    VACCINE, 1995, 13 (02) : 220 - 224
  • [25] HEPATITIS-A VACCINE - DEVELOPMENT, SAFETY AND IMMUNOGENICITY - DISCUSSION
    MELNICK, J
    SJOGREN, M
    GRACHEV, V
    LEMON, S
    DHONDT, E
    NISHIOKA, K
    WIEDERMANN, G
    LOLEKHA, S
    ANDRE, F
    BOUGHTON, C
    LEENTVAARKUIJPERS, A
    HATZ, C
    AMBROSCH, F
    NISHIOKA, K
    SHOUVAL, D
    MELNICK, J
    DESMYTER, J
    KRUGMAN, S
    VACCINE, 1992, 10 : S146 - S147
  • [26] IMMUNOGENICITY AND SAFETY OF AN INACTIVATED HEPATITIS-A VACCINE IN ANTI-HIV POSITIVE AND NEGATIVE HOMOSEXUAL MEN
    HESS, G
    CLEMENS, R
    BIENZLE, U
    SCHONFELD, C
    SCHUNCK, B
    BOCK, HL
    JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (01) : 40 - 42
  • [27] SINGLE-DOSE INACTIVATED HEPATITIS-A VACCINE - RATIONALE AND CLINICAL-ASSESSMENT OF THE SAFETY AND IMMUNOGENICITY
    VANDAMME, P
    THOELEN, S
    MEHEUS, A
    SAFARY, A
    ANDRE, FE
    MATHEI, C
    JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (04) : 435 - 441
  • [28] IMMUNOGENICITY OF A HEPATITIS-A VACCINE
    FLEHMIG, B
    HAAGE, A
    HEINRICY, U
    PFISTERER, M
    JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A25 - A26
  • [29] CULTURED INACTIVATED HEPATITIS-A VIRAL VACCINE - SPECIFIC SAFETY
    KUSOV, YY
    ORLOVA, TM
    PANINA, LI
    KAZACHKOV, YA
    NELGA, IV
    ELBERT, LB
    KRUTYANSKAYA, GL
    POLESCHUK, VF
    SOBOL, AV
    TITOVA, IP
    KARPOVICH, LG
    KALASHNIKOVA, TV
    BALAYAN, MS
    VOPROSY VIRUSOLOGII, 1991, 36 (02) : 156 - 159
  • [30] IMMUNOGENICITY, SAFETY, AND CONSISTENCY OF AN INACTIVATED HEPATITIS-A VACCINE - A RANDOMIZED CONTROLLED MULTICENTER STUDY WITH 3 DIFFERENT VACCINE LOTS
    KALLINOWSKI, B
    THEILMANN, L
    GMELIN, K
    KOMMERELL, B
    HOFMANN, F
    SCHEIERMANN, N
    WOHLAND, B
    STICKL, H
    MAIWALD, H
    MORIABADI, FK
    BOCK, HL
    CLEMENS, R
    INNERE MEDIZIN, 1992, 19 (02) : 41 - 44